Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 4,276–4,300 of 27,380 studies, newest first · page 172 of 1096.

May 2025 25

  1. 2025-05-19

    Potentially Inappropriate Medication Use Among Patients With Dementia in Traditional Medicare and Medicare Advantage

    ✓ Peer-reviewed Health systems and care delivery Medical Care

    Key finding: MA-PD enrollees had significantly lower utilization of PIMs than standalone PDP enrollees: a 0.7 percentage-point [95% CI: 0.5, 0.8] lower prevalence of potentially harmful drug-disease interactions in older adults with dementia; a 3.1 percentage-point [2.6, 3.5] lower prevalence of potentially harmful drug-disease interactions in older adults with dementia and a history of falls; and a 0.5 percentage-point [0.4, 0.6] lower prevalence of high-risk medications in older adults. +2 more findings

  2. 2025-05-18

    The role of the components of PM2.5 in the incidence of Alzheimer’s disease and related disorders

    ✓ Peer-reviewed How common it is Environment International

    Key finding: We found positive associations between the 15 PM 2.5 components and the incidence of dementia and AD. +2 more findings

  3. 2025-05-16

    Distinct systemic impacts of Aβ42 and Tau revealed by whole-organism snRNA-seq

    ✓ Peer-reviewed Genetics Neuron

    Key finding: We found that Aβ42 primarily affects the nervous system, including sensory neurons, while Tau induces accelerated aging in peripheral tissues. +1 more finding

  4. 2025-05-16

    “You like to be in control of your own destiny to a degree, don't you?”: conscientious autonomy and planning for future care with dementia

    ✓ Peer-reviewed End-of-life care BMC Palliative Care

    Key finding: Participants sought to feel secure by following recommended practices, manage uncertainty, avoid crises, share burdens within families, and avoid poor end-of-life experiences. +4 more findings

  5. 2025-05-16

    Better Assessment of Illness Study (BASIL) II for Delirium Severity: Study Design, Variables, and Methods

    ✓ Peer-reviewed Clinical safety Journal of Geriatric Psychiatry and Neurology

    Key finding: PurposeDelirium is a common yet preventable complication of hospitalization, surgery and illness that is associated with poor outcomes.

  6. 2025-05-16

    Delirium as a Precursor to Dementia in Elderly Type 2 Diabetes Mellitus Patients

    ✓ Peer-reviewed Clinical safety The Journal of Clinical Psychiatry

    Key finding: Our findings confirm a strong association between delirium and an increased risk of dementia in elderly (≥65 years) T2DM patients, suggesting a potential causal link. +1 more finding

  7. 2025-05-16

    Sleep architecture and dementia risk in adults: an analysis of 5 cohorts from the Sleep and Dementia Consortium

    ✓ Peer-reviewed How common it is SLEEP

    Key finding: The pooled sample comprised 4657 participants (30% women) aged ≥ 60 years (mean age was 74 years at sleep assessment). +4 more findings

  8. 2025-05-16

    Trends in Home Health Care Among Traditional Medicare Beneficiaries With or Without Dementia

    ✓ Peer-reviewed Caregiving JAMA Network Open

    Key finding: Among the 13 604 086 traditional Medicare beneficiaries included in the study (mean [SD] age, 79.4 [7.7] years; 60.4% women), 27.7% had a diagnosis of dementia. +4 more findings

  9. 2025-05-16

    Harnessing artificial intelligence for transforming dementia care: Innovations in early detection and treatment

    ✓ Peer-reviewed Caregiving Brain Organoid and Systems Neuroscience Journal

    Key finding: Dementia, particularly Alzheimer's Disease, continues to be a significant global health concern, driven by increasing prevalence as the population ages.

  10. 2025-05-16

    Associations between sleep quality, plasma neurofilament light, and cognition in older adults without dementia

    ✓ Peer-reviewed Getting a diagnosis Translational Psychiatry

    Key finding: Multiple testing significance was corrected using false discovery rate, with results presented as Q-values. +2 more findings

  11. 2025-05-16

    Socially inclusive infrastructure for disaster risk reduction in urban planning: insights from the SADC region

    ✓ Peer-reviewed Prevention and risk Frontiers in Built Environment

    Key finding: In response to these challenges, the study recommends a paradigm shift in urban planning towards the adoption of future-oriented and participatory approaches.

  12. 2025-05-16

    Hearing impairment and dementia: cause, catalyst or consequence?

    ✓ Peer-reviewed Prevention and risk Journal of Neurology

    Key finding: The relationship between hearing impairment and dementia has attracted significant attention, the 2024 Lancet Commission report identifying hearing loss as the largest modifiable risk factor for dementia from mid-life. +1 more finding

  13. 2025-05-15

    Modifiable risk factor profiles moderate the effect of β-amyloid pathology on cognition in aging

    ✓ Peer-reviewed Prevention trials Neurobiology of aging

    Key finding: Linear mixed-effects models showed an attenuated effect of β-amyloid on non-memory cognition decline in positive profiles (positive-active: β=3.7, p = 0.008, positive-affective: β=3.7, p = 0.007) compared to the negative profile. +2 more findings

  14. 2025-05-15

    Genetic risk and plasma biomarkers of dementia with Lewy bodies in a Chinese population

    ✓ Peer-reviewed Biomarkers NPJ Parkinson's disease

    Key finding: As a result, the APOE ε4 allele significantly increased DLB risk (p = 1.84E-11), while rare missense variants of USP13 gene were first found to be suggestively associated with DLB risk (p = 1.31E-5). +3 more findings

  15. 2025-05-15
  16. 2025-05-15

    Dementia care management in primary care practices: a descriptive study among nurse practitioners

    ✓ Peer-reviewed Clinical safety BMC Family Practice

    Key finding: NPs reported that the quality of dementia care in their practices is poorer than the overall care provided. +4 more findings

  17. 2025-05-15

    Association of Cardiovascular‐Kidney‐Metabolic Syndrome With Cognitive Decline and Dementia: The ARIC Study Insights

    ✓ Peer-reviewed Long-term cohort studies Journal of the American Heart Association

    Key finding: Elevated CKM risk level is significantly associated with increased risks of cognitive decline and dementia incidence. +2 more findings

  18. 2025-05-15

    Neuroprotective, Antioxidant and Anti-Inflammatory Effect of Greek Pomegranate Seed Oil on N2a Neuroblastoma Cells and Mild Cognitive Impairment Patients

    ✓ Peer-reviewed Mild cognitive impairment Biology

    Key finding: Alzheimer’s disease (AD) remains a significant global health challenge with limited FDA-approved treatments, necessitating the search for novel preventive strategies. +2 more findings

  19. 2025-05-15

    Prognostic Value of a Multivariate Gut Microbiome Model for Progression from Normal Cognition to Mild Cognitive Impairment Within 4 Years

    ✓ Peer-reviewed Mild cognitive impairment International Journal of Molecular Sciences

    Key finding: Logistic regression models were built with baseline features that best discriminated between the two groups using an ANOVA-type statistical analysis. +4 more findings

  20. 2025-05-15

    Revealing heterogeneity in mild cognitive impairment based on individualized structural covariance network

    ✓ Peer-reviewed Mild cognitive impairment Alzheimer s Research & Therapy

    Key finding: In the ADNI dataset, MCI patients exhibited significant alterations in structural covariance edges, mainly involving the hippocampus, parahippocampal gyrus, and amygdala. +4 more findings

  21. 2025-05-15

    Could self-reporting sleep duration become an important tool in the prediction of dementia?

    ✓ Peer-reviewed Risk factors Expert Review of Neurotherapeutics

    Key finding: In preclinical studies, partial or complete sleep deprivation produced inflammation, oxidative stress, as well as increased tau hyperphosphorylation and amyloid-β burden. +1 more finding

  22. 2025-05-15

    Ethical issues associated with assistive technologies for persons living with dementia and their caregivers – An overview of reviews

    ✓ Peer-reviewed Caregiving Dementia

    Key finding: Assistive technologies hold significant potential to enhance the quality of life for persons with dementia and their caregivers by addressing key concerns related to safety, independence, and social inclusion. +3 more findings

  23. 2025-05-15

    Time-Dependent Risk of Dementia Following Epilepsy Diagnosis: A Nationwide Cohort Study in South Korea

    ✓ Peer-reviewed Getting a diagnosis Archives of Clinical Neuropsychology

    Key finding: Dementia risk was significantly higher in patients with epilepsy compared with that of controls (IRR: 3.65; 95% CI: 3.14-4.24), especially within the first 2 years post-diagnosis (aHR: 5.42; 95% CI: 4.30-6.83), peaking between 8 and 10 years (aHR: 8.25; 95% CI: 3.15-21.5). +4 more findings

  24. 2025-05-15

    Disparities in Early Lecanemab Uptake Among US Medicare Beneficiaries

    ✓ Peer-reviewed Treatments JAMA Network Open

    Key finding: This cross-sectional study examines lecanemeb update among Medicare fee-for-service beneficiaries with Alzheimer disease or mild cognitive impairment and evaluates whether there are disparities among potentially eligible patients.

  25. 2025-05-15

    Olfaction and Plasma Biomarkers of Alzheimer Disease and Neurodegeneration in the Atherosclerosis Risk in Communities Study

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: Our findings suggest that poor olfaction is associated with multiple AD-related and other neurodegenerative processes. +4 more findings

Browse the library by subject, with the full score breakdown →